LRCX · Lam Research Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-02 | Varadarajan Seshasayee |
Senior Vice President |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |
Employee Stock Option (Right to Buy)
|
27,480 |
| 2026-09-02 | Varadarajan Seshasayee |
Senior Vice President |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
12,270 |
| 2026-09-02 | Varadarajan Seshasayee |
Senior Vice President |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
27,480 |
| 2026-09-02 | Varadarajan Seshasayee |
Senior Vice President |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
27,480 |
| 2026-09-02 | Varadarajan Seshasayee |
Senior Vice President |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
20,000 |
| 2026-09-02 | Varadarajan Seshasayee |
Senior Vice President |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024. |
Employee Stock Option (Right to Buy)
|
12,270 |
| 2026-09-02 | Varadarajan Seshasayee |
Senior Vice President |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
12,270 |
| 2026-08-31 | Harter Ava |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
5,000 |
| 2026-08-06 | ARCHER TIMOTHY |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
30,000 |
| 2026-08-06 | ARCHER TIMOTHY |
President and CEO |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |
Employee Stock Option (Right to Buy)
|
30,000 |
| 2026-08-06 | ARCHER TIMOTHY |
President and CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
30,000 |
| 2026-08-05 | Harter Ava |
Chief Legal Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
5,790 |
| 2026-07-13 | TALWALKAR ABHIJIT Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
18,282 |
| 2026-07-02 | ARCHER TIMOTHY |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
30,000 |
| 2026-07-02 | ARCHER TIMOTHY |
President and CEO |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |
Employee Stock Option (Right to Buy)
|
30,000 |
| 2026-07-02 | ARCHER TIMOTHY |
President and CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
30,000 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,906 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,100 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
2,708 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
5,037 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
3,828 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
5,803 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
2,300 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,600 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
4,198 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,393 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
300 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
8,233 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
819 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
4,030 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
7,700 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,200 |
| 2026-06-12 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
2,345 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $352.824 to $353.805, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,172 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $347.383 to $348.355, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
6,592 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $342.415 to $343.39, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
3,644 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.595 to $362.550, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
2,604 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.762 to $358.70, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,880 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $346.383 to $347.359, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
3,442 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $337.00 to $337.97, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
974 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $353.818 to $354.743, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,461 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $340.278 to $341.249, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,277 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $362.58 to $363.57, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
5,717 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $354.805 to $355.746, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,331 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.19 to $339.15, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,083 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $349.409 to $350.260, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,517 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
36 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $348.391 to $349.351, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
4,334 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.60 to $361.54, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,756 |
| 2026-06-11 | BRANDT ERIC |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.75 to $356.709, inclusive The amount reported includes shares subject to unvested restricted stock units. |
Common Stock
|
1,653 |